ArticlePharmaceuticals (Basel, Switzerland)2021

Restoring Tumour Selectivity of the Bioreductive Prodrug PR-104 by Developing an Analogue Resistant to Aerobic Metabolism by Human Aldo-Keto Reductase 1C3.

Maria R Abbattista et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.